Delmar Pharma (DMPI) Names Saiid Zarrabian as Full-Time President and CEO
Tweet Send to a Friend
DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) today announced that the board of directors (the "Board") has appointed Saiid Zarrabian as the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
